Clinical Practice Guideline for the management of COVID-19 in pediatrics in the Social Security of Peru (EsSalud): Synthesis of evidence and recommendations
DOI:
https://doi.org/10.35434/rcmhnaaa.2024.173.2391Keywords:
COVID-19, Clinical practice guideline, Evidence-based medicine, GRADE approachAbstract
Introduction: Since the beginning of the COVID-19 pandemic, different drugs and medications have been used for the prevention and treatment of COVID-19 infection. Likewise, various investigations have been developed that evaluate the effectiveness and safety of these interventions, which have concluded that they generate more harm than benefit in patient management. For this reason, it is relevant to standardize the interventions that have proven to be effective and safe in the management of pediatric patients with COVID-19.
Objective: Provide evidence-based clinical recommendations for the management of COVID-19 in pediatrics.
Methods: A guideline development group (GEG) was formed that included pediatric specialists and methodologists. The GEG formulated 11 clinical questions to be answered by this CPG (Table 1). For its preparation, the GEG decided to carry out a rapid adaptation of the Guide for the care of critically ill adult patients with COVID-19 in the Americas of the Pan American Health Organization (PAHO). To formulate the recommendations, the evidence frameworks for decision (EtD) of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology were developed.
Results: This CPG addressed 11 clinical questions on management. Based on these questions, 21 recommendations were formulated (13 strong and 8 conditional), 19 good clinical practices (GCP), and 1 flow chart.
Conclusion: This article summarizes the methodology and conclusions based on evidence of the CPG for the management of COVID-19 in pediatrics in EsSalud.
Downloads
Metrics
References
Blumenthal D, Fowler EJ, Abrams M, Collins SR. Covid-19 - Implications for the Health Care System. N Engl J Med. 2020;383:1483-1488. doi: 10.1056/NEJMsb2021088
Organization WH. Coronavirus disease (COVID-19). https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19). Accessed 29 de diciembre del 2023.
LaRotta J, Escobar O, Ávila-Aguero ML, Torres JP, Sini de Almeida R, Morales GDC, Srivastava A. COVID-19 in Latin America: A Snapshot in Time and the Road Ahead. Infect Dis Ther. 2023;12:389-410. doi: 10.1007/s40121-022-00748-z
Atamari-Anahui N, Cruz-Nina ND, Condori-Huaraka M, Nuñez-Paucar H, Rondón-Abuhadba EA, Ordoñez-Linares ME, Pereira-Victoriod CJ. [Characterization of coronavirus disease 2019 (COVID-19) in children and adolescents in Latin American and the Caribbean countries: A descriptive study]. Medwave. 2020;20:e8025. doi: 10.5867/medwave.2020.08.8025
Hopkins J. Coronavirus Resource Center. Mortality Analyses. https://coronavirus.jhu.edu/data/mortality. Accessed 29 de diciembre del 2023.
Herrera-Añazco P, Uyen-Cateriano A, Mezones-Holguin E, Taype-Rondan A, Mayta-Tristan P, Malaga G, Hernandez AV. Some lessons that Peru did not learn before the second wave of COVID-19. Int J Health Plann Manage. 2021;36:995-998. doi: 10.1002/hpm.3135
Xiao F, Tang M, Yan K, Zhou W. Clinical features of infants with SARS-CoV-2 infection: a systematic review and meta-analysis. Ann Palliat Med. 2022;11:3394-3408. doi: 10.21037/apm-22-933
Cui X, Zhao Z, Zhang T, Guo W, Guo W, Zheng J, Zhang J, Dong C, Na R, Zheng L, et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J Med Virol. 2021;93:1057-1069. doi: 10.1002/jmv.26398
Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, Pennington AF, Danielson ML, DeSisto CL, Chevinsky JR, et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA Netw Open. 2021;4:e2111182. doi: 10.1001/jamanetworkopen.2021.11182
Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J, Anderson EJ, Weigel A, Monroe ML, Reeg L, et al. Risk Factors for Severe COVID-19 in Children. Pediatrics. 2022;149. doi: 10.1542/peds.2021-053418
Alvarado-Gamarra G, Estupiñan-Vigil M, Garcés-Ghilardi R, Domínguez-Rojas J, Del Águila O, Alcalá-Marcos K, Márquez Llanos R, Ecker L, Celis CR, Alva-Diaz C, et al. Short-, mid-, and long-term complications after multisystem inflammatory syndrome in children over a 24-month follow-up period in a hospital in Lima-Peru, 2020-2022. Front Pediatr. 2023;11:1232522. doi: 10.3389/fped.2023.1232522
Quincho-Lopez A, Chávez-Rimache L, Montes-Alvis J, Taype-Rondan A, Alvarado-Gamarra G. Characteristics and conflicting recommendations of clinical practice guidelines for COVID-19 management in children: A scoping review. Travel Med Infect Dis. 2022;48:102354. doi: 10.1016/j.tmaid.2022.102354
Yao L, Guyatt GH, Djulbegovic B. Can we trust strong recommendations based on low quality evidence? Bmj. 2021;375:n2833. doi: 10.1136/bmj.n2833
Health NIo. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) treatment guidelines 2021. https://www.covid19treatmentguidelines.nih.gov. Accessed 29 de diciembre del 2023.
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, Behrens EM, Kernan KF, Schulert GS, Seo P, et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis Rheumatol. 2022;74:e1-e20. doi: 10.1002/art.42062
Pediatría AEd. COVID 19 en Pediatría: valoración crítica de la evidencia. https://www.aeped.es/comite-pediatria-basada-en-evidencia/documentos/covid-19-en-pediatria-valoracion-critica-evidencia. Accessed 29 de diciembre del 2023.
Fraile Navarro D, McMullan B, Bowen AC. Clinical care of children and adolescents with COVID-19: recommendations from the National COVID-19 Clinical Evidence Taskforce. Med J Aust. 2022;216:489. doi: 10.5694/mja2.51510
Liu E, Smyth RL, Li Q, Qaseem A, Florez ID, Mathew JL, Amer YS, Estill J, Lu Q, Fu Z, et al. Guidelines for the prevention and management of children and adolescents with COVID-19. Eur J Pediatr. 2022;181:4019-4037. doi: 10.1007/s00431-022-04615-4
Schlapbach LJ, Andre MC, Grazioli S, Schöbi N, Ritz N, Aebi C, Agyeman P, Albisetti M, Bailey DGN, Berger C, et al. Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland. Front Pediatr. 2021;9:667507. doi: 10.3389/fped.2021.667507
Algarni AS, Alamri NM, Khayat NZ, Alabdali RA, Alsubhi RS, Alghamdi SH. Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations. World J Pediatr. 2022;18:83-90. doi: 10.1007/s12519-021-00499-w
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926. doi: 10.1136/bmj.39489.470347.AD
Andrews JC, Schünemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, Rind D, Montori VM, Brito JP, Norris S, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation’s direction and strength. J Clin Epidemiol. 2013;66:726-735. doi: 10.1016/j.jclinepi.2013.02.003
Organización Panamericana de la Salud 2021. Guía para el cuidado de pacientes adultos críticos con COVID-19 en las Américas. Versión 3, [Internet]. 2021 [cited 2022 Jul 19]. Available from: https://iris.paho.org/handle/10665.2/53894
Pan American Health Organization 2021. Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence. Rapid Review, 14 July 2021. PAHO/IMS/EIH/COVID-19/21-019 [Internet]. [cited 2021 Jul 19]. Available from: https://iris.paho.org/handle/10665.2/52719
COVID-19 - all types of questions | Browse | Living Overview of the Evidence (L·OVE) [Internet]. [cited 2022 Aug 1]. Available from: https://app.iloveevidence.com/covid-19
Organización Panamericana de la Salud. Directrices para la profilaxis y el manejo de pacientes con COVID-19 leve y moderada en América Latina y el Caribe. Versión abreviada, octubre del 2021 [Internet]. Washington D.C: Organización Panamericana de la Salud; 2021. [citado el 27 de enero de 2022]. Disponible en: https://iris.paho.org/handle/10665.2/55099
Sociedad Peruana de Medicina Intensiva (SPMI)/Sociedad Peruana de Pediatría (SPP). Documento de Consenso para el Manejo del Niño Crítico con COVID-19 [Internet]. Lima: SPMI y SPP; 2020 [citado el 27 de enero de 2022]. Disponible en: https://uciped.org/wp- content/uploads/2020/04/RECOMENDACIONES-PACIENTE-PEDIATRICO- CRITICO-COVID19.pdf
Instituto Nacional de Salud del Niño de San Borja. Guía técnica para el diagnóstico y tratamiento de COVID-19 en pediatría. 2020.
Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016;353:i2089
Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. Journal of clinical epidemiology. 2013;66(7):719-25
Instituto de Evaluación de Tecnologías en Salud e Investigación. Guía de Práctica Clínica para el Manejo de COVID-19: Guía en Versión Extensa. Versión 3, diciembre 2021. Lima: EsSalud; 2021
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Juan Manuel Ortiz Chicchon, Lesly Chávez-Rimache, Matilde Emperatriz Estupiñán Vigil, Giancarlo Alvarado-Gamarra, Manuel Eduardo Munaico Abanto, Renato Díaz Ruíz, Susana Villegas Alegre, Darwin Mauricio Silva Vásquez, Medalit Luna Vílchez, Paulo Delgado Seminario, Stefany Salvador-Salvador, Lourdes Carrera-Acosta, Alvaro Taype-Rondan, Vladimir Ernesto Santos-Sánchez, Noé Atamari-Anahui
This work is licensed under a Creative Commons Attribution 4.0 International License.
